A/S, a global healthcare company specializing in diabetes care and other chronic conditions, has been at the forefront of the rapidly expanding GLP-1 market. With a market capitalization of $376.79 ...

Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has another enormous opportunity that's getting very little attention.

Mounjaro and Zepbound are by far Lilly's fastest ... Verzenio's performance in 2024 underscores how expanded indications for medications can accelerate their performance and help contribute ...

Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...

NPA chairman Nick Kaye told the PA news agency that while obesity is "one of the biggest challenges facing" the UK, they are ...

Pharmacists say they are aware of people being wrongly prescribed the drugs who have previously had eating disorders, or ...

The National Pharmacy Association (NPA) has written to regulators calling for tougher rules to be introduced around sale of ...

Britain’s pharmacists have called for tougher regulation of weight-loss drugs after reports showed some online sellers have ...

Pharmacy leaders have issued a warning over the online sale of weight-loss jabs insisting there is still a risk to patient ...

Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.